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Objective: This study sought to explore the diagnostic insight of cardiovascular magnetic 
resonance (CMR)-derived wave intensity analysis to better study systolic dysfunction in 
young patients with chronic diastolic dysfunction and preserved ejection fraction (EF), 
comparing it against other echocardiographic and CMR parameters.
Background: Evaluating systolic and diastolic dysfunctions in children is challenging, 
and a gold standard method is currently lacking.
Methods: Patients with presumed diastolic dysfunction [n = 18; nine aortic stenosis 
(AS), five hypertrophic, and four restrictive cardiomyopathies] were compared with 
age-matched control subjects (n = 18). All patients had no mitral or aortic incompe-
tence, significant AS, or reduced systolic EF. E/A ratio, E/E′ ratio, deceleration time, 
and isovolumetric contraction time were assessed on echocardiography, and indexed 
left atrial volume (LAVi), acceleration time (AT), ejection time (ET), and wave intensity 
analyses were calculated from CMR. The latter was performed on CMR phase-contrast 
flow sequences, defining a ratio of the peaks of the early systolic forward compression 
wave (FCW) and the end-systolic forward expansion wave (FEW).
results: Significant differences between patients and controls were seen in the 
E/E′ ratio (8.7 ±  4.0 vs. 5.1 ±  1.3, p =  0.001) and FCW/FEW ratio (2.5 ±  1.6 vs. 
7.2 ±  4.2 ×  10−5  m/s, p <  0.001), as well as—as expected—LAVi (80.7 ±  22.5 vs. 
51.0 ± 10.9 mL/m2, p < 0.001). In particular, patients exhibited a lower FCW (2.5 ± 1.6 
vs. 7.2 ± 4.2 × 10−5 m/s, p < 0.001) in the face of preserved EF (67 ± 11 vs. 69 ± 5%, 
p = 0.392), as well as longer isovolumetric contraction time (49 ± 7 vs. 34 ± 7 ms, 
p < 0.001) and ET/AT (0.35 ± 0.04 vs. 0.27 ± 0.04, p < 0.001).
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inTrODUcTiOn
Assessment of systolic and diastolic dysfunctions in pediatric 
patients poses difficulties due to the lack of a “gold standard” 
diagnostic biomarker. Currently, ventricular function, in 
particular diastolic dysfunction, is best assessed using catheter-
based techniques, though these are invasive in nature and present 
technical limitations (1). Echocardiography offers a non-invasive 
alternative, including detection of early myocardial dysfunction 
before any detectable change in ejection fraction (EF) (2), but 
it also presents limitations, partly due to the fact that existing 
normal echocardiographic values have too broad a range in the 
pediatric population (3).
In the adult population, up to 50% of elderly patients with heart 
failure have a normal ejection fraction (HFNEF) (4). This entity 
has also been observed in the pediatric literature, with several 
pediatric cardiac diseases that can present with diastolic dysfunc-
tion in the face of a normal EF. These include congenital aortic 
stenosis (AS) (5), hypertrophic cardiomyopathy (HCM) (6), and 
restrictive cardiomyopathy (RCM) (6), where young patients had 
findings consistent with diastolic dysfunction and normal EF. 
With the current diagnostic tests having potential limitations in 
children (and also in adults), we sought to assess a novel index 
obtained from wave intensity analysis [derived non-invasively 
from cardiovascular magnetic resonance (CMR) data] in children 
with a high likelihood of diastolic dysfunction but normal EF, in 
order to gather better insight into their ventricular function.
Wave intensity represents energy flux per unit area carried by 
waves traveling in the cardiovascular network (7). This hemo-
dynamic quantity carries information on interactions between 
the heart and the vasculature, i.e., ventriculoarterial coupling 
(8–10). Early work in this context suggested the potential of this 
method to provide insight into ventricular filling mechanics and 
speculated that it could help in the detection and characteriza-
tion of diastolic dysfunction (11). This article aims to explore the 
diagnostic insight of CMR-derived wave intensity analysis in a 
group of children with preserved EF and chronic diastolic dys-
function, as a way to better study systolic dysfunction in patients 
with diastolic dysfunction.
MaTerials anD MeThODs
Patient Population
We retrospectively identified a total of 31 patients who had under-
gone both CMR and detailed echocardiogram and were labeled 
to have presumed diastolic dysfunction. The datasets from these 
patients were then subjected to strict inclusion criteria for further 
analysis with wave intensity, namely:
 (a) Dilated left atrium (LA) on CMR and echocardiogram 
(Z-score ≥ +2.0)
 (b) Normal EF ≥ 55% on CMR
 (c) No mitral valve stenosis or regurgitation
 (d) No significant AS (Vmax gradient <  30  mmHg) or aortic 
regurgitation.
Eighteen subjects fitted the criteria, whereby no study patient 
had mitral or aortic incompetence, significant AS or reduced 
systolic EF:
• Nine patients had congenital AS—four patients had neonatal 
balloon aortic valvuloplasty followed by Ross procedure (pul-
monary autograft aortic valve replacement and pulmonary 
homograft procedure) to treat residual AS and five patients 
had neonatal surgical valvotomy, followed by Ross procedure.
• Five patients had HCM with the evidence of dilated LA on 
CMR or echocardiography, normal EF on CMR (>55%), no 
left ventricular outflow tract obstruction, and no history of 
myomectomy or alcohol ablation.
• Four patients had idiopathic RCM based on high end-diastolic 
pressures (EDP) on previous catheterization, echocardio-
graphic features reported as restrictive physiology (dilated LA 
and Doppler evidence of restriction), and normal EF (>55%).
Eighteen healthy age-matched controls with no current or 
past evidence of phenotypic cardiovascular disorders served as 
our control subjects.
echocardiographic Data
All patients had an echocardiographic examination as a part of 
their assessment. Diastolic function assessment included pulsed 
Doppler of the mitral inflow and tissue Doppler imaging (TDI). 
All measurements of diastolic variables were retrospectively 
re-measured by a single echocardiographer. Conventional 
pulsed Doppler indices of diastolic function, peak early (E) and 
late (A) diastolic trans-mitral velocities, E/A ratio, and E-wave 
deceleration time (DT) were measured from the spectral Doppler 
signal of the mitral valve inflow, together with the isovolumetric 
contraction time (IVCT). Pulsed-wave TDI velocities were 
obtained from the septal mitral annulus (apical four-chamber 
view). TDI measurements for each myocardial segment included 
peak early diastolic velocity (E′) and peak late diastolic velocity 
(A′). Only tracings that demonstrated a clear E′ were used. Each 
TDI velocity was measured on three consecutive cardiac cycles 
and averaged for the analysis. The ratio of peak early diastolic 
mitral inflow velocity and early septal TDI velocity (E/E′) was 
calculated. Examples of echocardiographic data are provided in 
Figure 1.
conclusion: This study shows that the wave intensity-derived ratio summarizing systolic 
and diastolic function could provide insight into ventricular function in children, on top 
of CMR and echocardiography, and it was here able to identify an element of ventricular 
dysfunction with preserved EF in a small group of young patients.
Keywords: systolic function, diastolic function, wave intensity analysis, ventricular mechanics, cardiovascular 
magnetic resonance
FigUre 1 | echocardiographic data from a patient showing diastolic dysfunction: (a) trans-mitral Doppler E/A = 2.4, deceleration time = 111 ms; (B) 
tissue Doppler imaging E′ = 0.07, a high E/E′ ratio of 18.1 signifying diastolic dysfunction.
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cMr Data
Cardiovascular magnetic resonance data were acquired with a 
1.5-T scanner (Avanto; Siemens Medical Solutions, Erlangen, 
Germany). Flow quantification was performed using phase-
contrast sequences, with through-plane flow data acquired with 
the use of retrospective cardiac gating. Appropriate velocity-
encoding values were set ~250  cm/s for through-plane flow 
quantification. Indicative parameters for the flow phase-contrast 
sequences were TR/TE =  27/3  ms, flip angle =  30°, and pixel 
size = 1.25 × 1.25, with a field of view = 240 × 320 or smaller. 
Acquisition parameters were adapted if necessary to optimize the 
quality of the scan for each case. Retrospectively gated, balanced, 
steady-state free precession cine images were acquired in the ver-
tical long-axis (two-chamber), four-chamber, and the short-axis 
covering the entirety of both ventricles (9–12 slices). Myocardial 
late gadolinium enhancement for tissue characterization was 
performed in the long- and short-axis planes, using inversion 
recovery prepared gradient recalled echo sequence 10–15  min 
after injection of gadolinium (Dotarem®, gadoterate meglumine, 
Gd-DOTA, 0.1 mmol/kg; Guerbet, Paris, France). Inversion time 
was adjusted (250–350  ms) in order to null the normal viable 
myocardium. All postprocessing was carried out using in-house 
written plug-ins (OsiriX; Pixmeo, Geneva, Switzerland).
Left ventricular end-diastolic and end-systolic volumes were 
measured and indexed for BSA (i). The stroke volume, EF, and 
cardiac output were derived from these measurements. On top 
of the functional data, LA area and length were also measured 
from the two-chamber and four-chamber views, respectively, 
at the end of ventricular systole. The LA area was obtained by 
tracing its endocardial border excluding the pulmonary veins, LA 
appendage, and mitral valve recess. These parameters were used 
to calculate LA volume (LAV) using the formula (12, 13):
 LAV
A ch A4ch
L
=
8 2
3
( )( )
pi
 
where A2ch is the area of the two-chamber view, A4ch is the area 
of the four-chamber view, and L is the shorter of the two LA length 
measurements (L2Ch and L4Ch) from these views (Figure 2).
The aortic velocity waveforms were used to compute peak 
velocity, acceleration time (AT), and ejection time (ET).
Wave intensity analysis
Wave intensity carries important information on ventriculoarte-
rial interactions as well as time-domain information on wave 
reflections (7). By formulating wave intensity in terms of area 
(A) and velocity (U) differentials, i.e. dI = dUdlnA, as opposed 
to the traditional pressure-based formulation, i.e., dI =  dPdU, 
the analysis can be performed non-invasively based on CMR 
phase-contrast acquisitions. Wave intensity information was 
derived from CMR data using a previously proposed methodol-
ogy (14). The image processing was carried out using an in-house 
written plug-in (OsiriX), whereby images are semiautomatically 
segmented to extract the A and U signals from the ascending 
aortic flow sequence and these are then combined to compute dI.
The following two dominant waves are identified in a typical dI 
pattern: a forward compression wave (FCW) at systolic ejection 
and a forward expansion wave (FEW) at end systole (Figure 3). 
Previous work has linked FCW with ventricular dP/dt and FEW 
with diastolic time relaxation constant (τ), suggesting dI as a clini-
cally useful parameter for concurrently assessing LV systolic and 
early diastolic performance (15). Not only systolic and diastolic 
dysfunctions are unlikely to occur in isolation, but furthermore 
a desirable test for patients with heart failure has been suggested 
to be a non-invasive assessment of systolic and diastolic left 
ventricular functions together, not to uncouple systolic from 
diastolic function (16). For this reason, a single, non-dimensional 
parameter is proposed here and calculated as the ratio of dI peaks, 
i.e., =FCW/FEW, as an indicator of ventricular function. The 
rationale for choosing this parameter was based on the observa-
tion that systolic and diastolic dysfunctions often coexist, and 
FigUre 2 | Balanced-ssFP cine images of: (a) two-chamber (2ch) view and (B) four-chamber (4ch) at end systole showing measurement of the left 
atrial volume (laV) by the biplane area–length method. The atrial endocardial border was traced to delineate left atrium (LA) area excluding the pulmonary 
veins, LA appendage, and mitral valve recess. LA volume was measured as reported in the Section “Materials and Methods.”
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the combined ratio would likely be more informative of cardiac 
dysfunction than systolic/diastolic measures alone (17, 18).
Data analysis
All data processing was carried out in Matlab (MathWorks, 
Natick, MA, USA). Healthy controls and patients were compared 
for the following parameters: E/A, E/E′, DT, and IVCT from 
echocardiography; EF, indexed left atrial volume (LAVi) and 
AT/ET from CMR; and FCW/FEW. Aortic distensibility (D) was 
inferred from wave speed (c) according to the Bramwell–Hill 
formula, c2 = 1/ρD, with ρ = density of blood and c estimated as 
a part of the CMR-based wave intensity analysis.
statistical analysis
Statistical analysis was carried out with commercial software 
(SPSS v.22; SPSS Inc., Chicago, IL, USA). Data are presented as 
mean ±  SD. Comparisons of continuous variables of unpaired 
samples between groups (controls vs. patients) were performed 
using unpaired two-tailed Student’s t-test, or Mann–Whitney U 
test for non-parametric data. Linear correlation among different 
variables was assessed using the Pearson r coefficient. A value of 
p < 0.05 was regarded as statistically significant.
resUlTs
Baseline characteristics, CMR, echocardiography, and wave 
intensity data between patients and healthy control subjects 
are presented in Table  1. Baseline characteristics showed that 
patients were age-matched with healthy controls (13.6 ± 4.5 vs. 
14.9 ± 2.2 years, p = 0.259). There were no blood pressure differ-
ences between the two groups.
echocardiographic evaluation
Indices of conventional pulsed-wave Doppler across the mitral 
valve and TDI are listed in Table  1. There was no significant 
difference of E/A ratio and DT between patients and healthy 
controls. E/E′ showed a statistically significant difference between 
patients and controls (8.7 ± 4.0 vs. 5.1 ± 1.3 p = 0.001). IVCT was 
significantly longer in patients compared to controls (49 ± 7 vs. 
34 ± 7 ms, p < 0.001).
cMr evaluation
Left ventricular functional assessment showed no significant dif-
ferences of the indexed volumes (LV ESVi and LV EDVi) and EF 
(67 ± 11 vs. 69 ± 5%, p = 0.392) between patients and controls. 
The LAVi, as expected, was significantly larger in patients with 
presumed diastolic dysfunction compared to healthy controls 
(80.7 ± 22.5 vs. 51.0 ± 10.9 mL/m2, p < 0.001, Table 1). On tissue 
characterization imaging, four AS patients and one patient with 
idiopathic RCM displayed endomyocardial fibroelastosis (EFE). 
Furthermore, patients exhibited lower peak aortic velocity, as 
well as significantly longer AT and similar ET, resulting in AT/
ET = 0.35 ± 0.04 in patients and AT/ET = 0.27 ± 0.04 in controls 
(p < 0.001).
Wave intensity analysis
Peak FCW was significantly lower in patients compared with nor-
mal healthy controls (2.5 ± 1.6 vs. 7.2 ± 4.2 × 10−5 m/s, p < 0.001), 
while peak FEW was not significantly different (7.8 ±  4.2 vs. 
6.9 ± 3.9 × 10−6 m/s, p = 0.551). The ratio FCW/FEW was thus 
significantly lower in patients (3.7 ± 2.7 vs. 12.7 ± 7.9, p < 0.001). 
Pearson correlation of the FCW/FEW with well-known echo-
cardiographic and CMR biomarkers of diastolic dysfunction is 
shown in Table 2. The FCW/FEW ratio had a significant moder-
ate negative correlation with E/E′ (r = −0.325, p = 0.027) and a 
significant negative correlation with presence of EFE (r = −0.343, 
p = 0.020), while the correlation with LAVi was just above the 
significance threshold (r = −0.264, p = 0.060). Furthermore, a 
significant negative correlation was found between FCW and 
IVCT measured from echocardiography (r = −0.459, p = 0.012) 
TaBle 2 | Values of Pearson’s coefficient (r) and p values for correlations 
between forward compression wave/forward expansion wave ratio and 
other parameters.
Variables Pearson’s (r) p-Value
Age 0.005 0.487
SBP 0.047 0.393
DBP 0.156 0.181
E/A 0.163 0.171
E/E′ −0.325 0.027*
Deceleration time 0.028 0.473
LV ejection fraction 0.226 0.093
Endomyocardial fibroelastosis −0.343 0.02*
Indexed left atrial volume −0.264 0.060
Distensibility 0.618 <0.001*
*p < 0.05.
TaBle 1 | summary of demographic, echocardiography, cMr, and wave 
intensity data for patients and healthy controls groups.
Variables Patients (n = 18) controls 
(n = 18)
p-Value
Demographic data
Age (years) 13.6 ± 4.5 14.9 ± 2.2 0.259
BSA (m2) 1.4 ± 0.4 1.7 ± 0.4 0.005*
Sex (F/M) 7/11 4/14 0.04*
HR (bpm) 78 ± 12 72 ± 12 0.157
DBP (mmHg) 62 ± 11 62 ± 10 0.940
SBP (mmHg) 104 ± 14 106 ± 10 0.520
echocardiography data
E/A 2.3 ± 1.1 2.5 ± 1.2 0.625
Deceleration time (ms) 137.0 ± 53.1 154.3 ± 48.5 0.307
E/E′ 8.7 ± 4.0 5.1 ± 1.3 0.001*
IVCT (ms) 49 ± 7 34 ± 7 <0.001*
cMr data
LV ESVi (mL/m2) 23.0 ± 9.5 23.6 ± 6.7 0.817
LV EDVi (mL/m2) 68.4 ± 11.9 75.2 ± 12.6 0.099
iSV (mL/m2) 43 ± 10 52 ± 8 0.010*
LV ejection fraction (%) 67 ± 11 69 ± 5.0 0.392
Indexed left atrial volume (mL/m2) 80.7 ± 22.5 51.0 ± 10.9 <0.001*
Peak U (cm/s) 62 ± 16 90 ± 14 <0.001*
Acceleration time (AT) (ms) 117 ± 21 92 ± 15 <0.001*
Ejection time (ET) (ms) 332 ± 36 341 ± 21 0.334
AT/ET 0.35 ± 0.04 0.27 ± 0.04 <0.001*
Wia data
Distensibility (×10−3 1/mmHg) 4.3 ± 3.7 6.5 ± 4.3 0.116
Wave speed (m/s) 8.2 ± 7.2 5.3 ± 2.7 0.115
Peak forward compression wave 
(FCW) (x10-5 m/s)
2.5 ± 1.6 7.2 ± 4.2 <0.001*
Peak forward expansion wave 
(FEW) (×10−6 m/s)
7.8 ± 4.2 6.9 ± 3.9 0.551
FCW/FEW 3.7 ± 2.9 12.7 ± 7.9 <0.001*
*p < 0.05.
FigUre 3 | example of wave intensity analysis methodology from a 
patient, showing positioning of the slice for flow assessment (a) and 
modulus (B) and phase (c) images of the phase-contrast acquisition. 
Aortic velocity (D) and area (e) are semiautomatically extracted and 
combined for wave speed calculation (F) and wave intensity analysis (g): c, 
wave speed; A, area; U, aortic velocity; FCW, forward compression wave 
(early systole); FEW, forward expansion wave (end systole).
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and between FCW and AT/ET derived from CMR aortic velocity 
data (r = −0.386, p = 0.018).
DiscUssiOn
In this study, we demonstrate the diagnostic potential of a novel, 
wave intensity analysis biomarker, derived from CMR flow data. 
Importantly, the wave intensity data (i.e., reduced FCW) provided 
insight into an element of load-independent systolic dysfunction 
in children with normal EF and chronic diastolic dysfunction. 
This observation was corroborated by prolonged IVCT on the face 
of normal diastolic blood pressure; however, IVCT on its own is 
limited by the fact that invasive pressure data is needed in order to 
comment on systolic function. The systolic impairment was fur-
ther confirmed by observing aortic velocity waveforms, whereby 
peak velocity is significantly lower in patients who concurrently 
exhibit a longer AT. This indicates that peak aortic acceleration 
was lower, i.e., lower inotropy (19). Overall, FCW could then be 
a non-invasive marker for load-independent systolic dysfunction 
in the face of normal EF.
We have shown that the FCW/FEW ratio provided insight 
in the physiology of patients with chronic diastolic dysfunction 
despite normal EF when compared with more conventional 
6Ntsinjana et al. Non-Invasive Assessment of Ventricular Function 
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non-invasive parameters. Such a non-invasive measurement 
may prove particularly useful in the pediatric population, as 
diagnostic tools that are adequate for use in adult populations 
for the diagnosis of diastolic dysfunction fail to do so in pediatric 
patients, including echocardiographic parameters routinely used 
in the clinic (3).
Potential confounders for abnormal diagnostic tests were pur-
posefully eliminated in this study. All patients with mitral valve 
disease, aortic incompetence, or residual stenosis and those with 
reduced LV EF were excluded in an attempt to make the study 
group more homogenous. Our primary objective was to test the 
potential of the wave intensity data for assessment of sub-clinical 
ventricular dysfunction. There was no difference in EF between 
patients and control subjects but significantly increased LAVi 
in the patient group. This is important as there is a significant 
relationship between increased LAVi and elevated LV EDP as 
well as echocardiographic indices of diastolic dysfunction, as 
shown in adult patients (20, 21). We presume therefore that the 
abnormally increased LAVi in the diseased subjects in our study is 
due to chronic diastolic dysfunction, an entity previously shown 
in pediatric echocardiographic studies (13). The combination 
of these abnormal and normal measured parameters then gave 
us this study cohort with normal EF in the presence of diastolic 
dysfunction.
Our results agree with the literature with regard to echocar-
diographic parameters in children in that only the E/E′ was sig-
nificantly different between patients and healthy control subjects 
(3, 22, 23). As a proof of principle, the new biomarker was then 
correlated with the established diagnostic tests for diastolic dys-
function, correlating with the two reliable indicators of diastolic 
dysfunction, namely E/E′ and LAVi. An even stronger correlation 
was found between FCW/FEW and EFE. EFE was detected in 28% 
of the patients with presumed diastolic dysfunction, 80% of whom 
had congenital AS as a primary cardiac diagnosis. Physiologically, 
EFE renders the LV less distensible, thus potentially causing fur-
ther impairment of diastolic filling (24, 25). Though the majority 
of our patient group did not have overt heart failure, many of 
HFNEF has been attributed to LV remodeling associated with 
concentric hypertrophy and increased end-diastolic volume, 
hence increased LV stiffness (26, 27). LV systolic and diastolic 
dysfunctions have long been known to induce impaired relaxa-
tion; this has been proven to be true by a myocardial performance 
index previously proposed by Tei et al. (18), showing a positive 
correlation between myocardial performance index and τ. The 
Tei index is, however, limited by pseudonormalization in the 
face of HFNEF and largely susceptible to activation delay (28, 
29). Instead, the wave intensity biomarker could be used to com-
plement and/or augment already existing parameters in those 
patients with HFNEF. From a methodological perspective, this 
postprocessing methodology does not impinge on scan time (i.e., 
does not require additional sequences acquisition) and has been 
semi-automated to facilitate the analysis.
limitations and Future Directions
The first limitation is the small number of patients studied, 
partly due to strict inclusion criteria adopted to avoid clinical 
confounders. Second, this study was performed on patients with 
presumed rather than definitive diastolic dysfunction due to no 
pressure–volume loop data being available as a reference standard; 
however, we used acceptable non-invasive surrogates of diastolic 
dysfunction. Third, out-of-plane motion in CMR flow sequences 
may represent a problem for aortic area measurements. However, 
this movement has been quantified in the range of <1 cm (30, 
31), and assuming no significant tapering in the region of the 
ascending aorta and constant regional wall properties, area 
measurements should not be substantially affected. Finally, the 
diagnostic potential of the proposed wave intensity ratio should 
be tested in a larger cohort of prospective patients and we intend 
to carry this out in the near future.
cOnclUsiOn
This study suggests a novel, non-invasive biomarker for assessing 
sub-clinical ventricular dysfunction in pediatric patients, based 
on CMR-derived wave intensity analysis, with diagnostic capa-
bilities that appeared to perform better that the standard available 
parameters. This parameter could be easily implemented in rou-
tine CMR examinations (in both children and adults), providing 
additional and complementary information on combined systolic 
and diastolic performances.
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